Myval heart valve study for adults needing TAVI
Part of Heart & circulation clinical trials.
This trial studies whether the Myval THV (a new heart valve) is safe and effective for adults who need TAVI, a procedure to replace a narrowed heart valve without open-heart surgery. You may be considered if a heart team says you’re a good candidate for this valve procedure and you’re willing to join the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You (or your legal representative) must agree to join and sign the consent form.
- A heart team must say you are suitable for TAVI (valve replacement through a catheter).
- You must be considered suitable for implantation with all three study valve options.
- You must be willing to participate; if you (or your legal decision-maker) object, you can’t join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This study collects information from people who need a second heart valve placed inside a previously implanted one (called TAVI-in-TAVI). The goal is to learn more about how a specific valve (the Myval) works in this situation.
This registry tracks people getting a new heart valve called Myval. It's designed to see how well it works in real-world care.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This study compares regular monitoring (“clinical surveillance”) versus replacing the aortic valve using a minimally invasive procedure called TAVR for people with moderate aortic stenosis. It aims to see which approach better reduces symptoms or heart damage over time.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.